SFARI | Search Results for “cra”

Characterizing subcortical structural heterogeneity in autism.

Fellows-to-Faculty and Bridge to Independence Award Fellows

Processing of social and monetary rewards in autism spectrum disorders.

2023 Cross-Species Studies of ASD RFA — Informational session

On January 23, 2023, SFARI hosted an informational session on the 2023 Cross-Species Studies of ASD request for applications (RFA).

Paul Tesar, Ph.D.

Tesar joined the faculty at CWRU in 2010 and is currently the Dr. Donald and Ruth Weber Goodman Professor of Innovative Therapeutics at CWRU School of Medicine. His laboratory has pioneered new regenerative approaches to treat myelin disorders of the central nervous system, including multiple sclerosis, neuromyelitis optica, pediatric leukodystrophies, cerebral palsy and brain cancer.

Clinical trial of arbaclofen for 16p11.2 deletion has launched

Clinical Research Associates, L.L.C., an affiliate of the Simons Foundation, has recently launched a randomized controlled trial to test the safety, tolerability and efficacy of arbaclofen in 16p11.2 BP4-BP5 deletion syndrome.

GABA_B receptor modulation of visual sensory processing in adults with and without autism spectrum disorder.

Precise genome editing across kingdoms of life using retron-derived DNA.

The meaning of significant mean group differences for biomarker discovery.